Go back

Crick lab leader joins Cancer Research UK

Charles Swanton, leader of the Translational Cancer Therapeutics Laboratory at the Francis Crick Institute, has been appointed as the chief clinician at Cancer Research UK.

Swanton, who is a professor of personalised cancer medicine at University College London, will join the charity’s executive board in late summer, CRUK announced on 21 June. 

He practices as a medical oncologist at University College London Hospitals and was a founding scientist of Achilles Therapeutics, a spinout that develops immunotherapies for cancer. Swanton is also running a clinical study that assesses how cancer develops, called TRACERx.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.